Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2091]

Ecobiosocial factors and risk for colorectal cancer cluster: Two- and three-way...

Dr Sharifah Saffinas Syed Soffian - Ministry of Health Malaysia, Universiti...

Ecobiosocial factors and risk for colorectal cancer cluster: Two- and three-way interactions ( Dr Sharifah Saffinas Syed Soffian - Ministry of Health Malaysia, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia )

Relationship between governance and cervical cancer control

Dr Nuhu Tumba - Bingham University New Karu, Abuja, Nigeria

Relationship between governance and cervical cancer control ( Dr Nuhu Tumba - Bingham University New Karu, Abuja, Nigeria )

Precision oncology: Optimising therapeutic strategies in mHSPC and mCRPC

Prof. Gert Attard, Prof. Dr. Dr. Philipp Mandel, Dr. Lynda Corrigan

Precision oncology: Optimising therapeutic strategies in mHSPC and mCRPC ( Prof. Gert Attard, Prof. Dr. Dr. Philipp Mandel, Dr. Lynda Corrigan )

Unlocking the potential of liquid biopsy applications in personalised care for...

Dr Yue Zhao - University Hospital of Cologne, Cologne, Germany

Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer ( Dr Yue Zhao - University Hospital of Cologne, Cologne, Germany )

Advancements in minimal residual disease detection in myeloma

Dory Abelman, PhD Candidate - University of Toronto, Ontario, Canada

Advancements in minimal residual disease detection in myeloma ( Dory Abelman, PhD Candidate - University of Toronto, Ontario, Canada )

New classification for identifying HR myeloma based on cytogenetic abnormalities

Dr Jill Corre - IUCT Oncopole, Toulouse, France

New classification for identifying HR myeloma based on cytogenetic abnormalities ( Dr Jill Corre - IUCT Oncopole, Toulouse, France )

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM

Dr Elias Mai - Heidelberg University, Heidelberg, Germany

Made to measure: Choosing the optimal regimen in transplant-eligible NDMM ( Dr Elias Mai - Heidelberg University, Heidelberg, Germany )

Revolutionising myeloma treatment through immune profiling

Dr Romanos Sklavenitis-Pistofidis - Dana-Farber Cancer Institute, Boston, USA

Revolutionising myeloma treatment through immune profiling ( Dr Romanos Sklavenitis-Pistofidis - Dana-Farber Cancer Institute, Boston, USA )

Contribution of constitutional BRCA1 promoter methylation to early-onset and...

Dr Muhammad Usman Rashid - Shaukat Khanum Memorial Cancer Hospital & Research...

Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan ( Dr Muhammad Usman Rashid - Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan )

Predicting tumour mutations from pathology images may help increase...

Dr Rom Leidner - Providence Cancer Institute, Portland, USA

Predicting tumour mutations from pathology images may help increase personalised medicine utilisation ( Dr Rom Leidner - Providence Cancer Institute, Portland, USA )

Advancements in paediatric Acute lymphoblastic leukemia management

Dr Ruchi Aujla - Balco Medical Center, Raipur, India

Advancements in paediatric Acute lymphoblastic leukemia management ( Dr Ruchi Aujla - Balco Medical Center, Raipur, India )

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC

Dr Marina Garassino - University of Chicago, Chicago, USA

Comment: Trial updates from GALAXIES Lung-201 and RELATIVITY-104 in NSCLC ( Dr Marina Garassino - University of Chicago, Chicago, USA )

More from ecancer